Literature DB >> 7002787

Characterization of Shigella dysenteriae 1 (Shiga) toxin purified by anti-Shiga toxin affinity chromatography.

A D O'Brien, G D LaVeck, D E Griffin, M R Thompson.   

Abstract

Shigella dysenteriae 1 (Shiga) toxin was purified from whole-cell lysates by antitoxin affinity column chromatography, radioiodination, and Sephacryl S-200 gel filtration of 125I-labeled affinity column eluates. Two chromatographic peaks were observed. The percentage of radioactivity in peak I samples immunoprecipitated with antitoxin ranged from 95 to 100%. A pool of samples from this first peak contained over 90% of the HeLa-cell-cytotoxic units applied to the column and was enterotoxic for rabbit ileal loops and lethal for rabbits. This radiolabeled material migrated as a single cytotoxic band after nondenaturing polyacrylamide gel electrophoresis, but formed three bands, of 33,000, 29,000, and 4,000 to 7,000 daltons, after sodium dodecyl sulfate-polyacrylamide gel electrophoresis. In addition, material estimated as 7,000 daltons by Bio-Gel P-10 chromatography could be generated by treatment of S-200 peak I samples with 8 M urea. Pooled fractions from the second S-200 peak were separable into several low-molecular-weight peaks on a P-10 column. One of these P-10 peaks (7,000 daltons) was 27% immunoprecipitable with antitoxin. These data indicate that three of the known biological activities of Shiga toxin are associated with a 33,000-dalton substance which can be dissociated into 29,000- and 4,000- to 7,000-dalton components.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7002787      PMCID: PMC551292          DOI: 10.1128/iai.30.1.170-179.1980

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  20 in total

1.  Rapid isolation of antigens from cells with a staphylococcal protein A-antibody adsorbent: parameters of the interaction of antibody-antigen complexes with protein A.

Authors:  S W Kessler
Journal:  J Immunol       Date:  1975-12       Impact factor: 5.422

2.  The neurotoxin of Shigella shigae. I. Production, purification and properties of the toxin.

Authors:  W E VAN HEYNINGEN; G P GLADSTONE
Journal:  Br J Exp Pathol       Date:  1953-04

3.  The pathogenesis of shigella diarrhea. II. Enterotoxin-induced acute enteritis in the rabbit ileum.

Authors:  G T Keusch; G F Grady; A Takeuchi; H Sprinz
Journal:  J Infect Dis       Date:  1972-07       Impact factor: 5.226

4.  Protein iodination with solid state lactoperoxidase.

Authors:  G S David; R A Reisfeld
Journal:  Biochemistry       Date:  1974-02-26       Impact factor: 3.162

5.  A simplified method for cyanogen bromide activation of agarose for affinity chromatography.

Authors:  S C March; I Parikh; P Cuatrecasas
Journal:  Anal Biochem       Date:  1974-07       Impact factor: 3.365

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  Production and characterization of exotoxin(s) of Shigella dysenteriae type 1.

Authors:  J McIver; G F Grady; G T Keusch
Journal:  J Infect Dis       Date:  1975-05       Impact factor: 5.226

8.  Inhibition of in vitro protein synthesis by Shigella dysenteriae 1 toxin.

Authors:  M R Thompson; M S Steinberg; P Gemski; S B Formal; B P Doctor
Journal:  Biochem Biophys Res Commun       Date:  1976-08-09       Impact factor: 3.575

Review 9.  Shigellosis and Escherichia coli diarrhea: relative importance of invasive and toxigenic mechanisms.

Authors:  A D O'Brien; M K Gentry; M R Thompson; B P Doctor; P Gemski; S B Formal
Journal:  Am J Clin Nutr       Date:  1979-01       Impact factor: 7.045

10.  Isolation and characterization of Shigella shigae cytotoxin.

Authors:  S Olsnes; K Eiklid
Journal:  J Biol Chem       Date:  1980-01-10       Impact factor: 5.157

View more
  31 in total

1.  Cloning of genes for production of Escherichia coli Shiga-like toxin type II.

Authors:  J W Newland; N A Strockbine; R J Neill
Journal:  Infect Immun       Date:  1987-11       Impact factor: 3.441

2.  Purification of Shiga toxin and Shiga-like toxins I and II by receptor analog affinity chromatography with immobilized P1 glycoprotein and production of cross-reactive monoclonal antibodies.

Authors:  A Donohue-Rolfe; D W Acheson; A V Kane; G T Keusch
Journal:  Infect Immun       Date:  1989-12       Impact factor: 3.441

3.  Natural and recombinant interferons inhibit epithelial cell invasion by Shigella spp.

Authors:  D W Niesel; C B Hess; Y J Cho; K D Klimpel; G R Klimpel
Journal:  Infect Immun       Date:  1986-06       Impact factor: 3.441

Review 4.  Shiga and Shiga-like toxins.

Authors:  A D O'Brien; R K Holmes
Journal:  Microbiol Rev       Date:  1987-06

5.  The mode of action of Shiga toxin on peptide elongation of eukaryotic protein synthesis.

Authors:  T G Obrig; T P Moran; J E Brown
Journal:  Biochem J       Date:  1987-06-01       Impact factor: 3.857

6.  Two toxin-converting phages from Escherichia coli O157:H7 strain 933 encode antigenically distinct toxins with similar biologic activities.

Authors:  N A Strockbine; L R Marques; J W Newland; H W Smith; R K Holmes; A D O'Brien
Journal:  Infect Immun       Date:  1986-07       Impact factor: 3.441

7.  Immunochemical and cytotoxic activities of Shigella dysenteriae 1 (shiga) and shiga-like toxins.

Authors:  A D O'Brien; G D Laveck
Journal:  Infect Immun       Date:  1982-03       Impact factor: 3.441

8.  Purification and biological characterization of shiga toxin from Shigella dysenteriae 1.

Authors:  J E Brown; D E Griffin; S W Rothman; B P Doctor
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

9.  Natural and experimental infection with an attaching and effacing strain of Escherichia coli in calves.

Authors:  R A Moxley; D H Francis
Journal:  Infect Immun       Date:  1986-08       Impact factor: 3.441

10.  Release of Shiga toxin from Shigella dysenteriae 1 by polymyxin B.

Authors:  D E Griffin; P Gemski
Journal:  Infect Immun       Date:  1983-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.